Maternal serum screening and 22q11.2 deletion syndrome [6]

American Journal of Medical Genetics, Part A

Volumn 143, Issue 4, 2007, Pages 410-411

  Begleiter, Michael L ^a,b   Lund, Molly M ^a,b   Atherton, Andrea M ^a,b   Buchholz, Jaada D ^a,b   Ardinger, Holly H ^a,b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; DELETION MUTANT; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GESTATION PERIOD; HUMAN; LETTER; MATERNAL SERUM; MOLECULAR PROBE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; TRISOMY 18;

ABNORMALITIES, MULTIPLE; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 22; ESTRIOL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INHIBINS; SYNDROME; TRISOMY;

EID: 33846821887     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31616     Document Type: Letter

References (3)

1. Devriendt K, Fryns J-P, Mortier G. 1998. The annual incidence of DiGeorge/Velocardiofacial syndrome. J Med Genet 35:789-790.
2. Wilson DI, Cross IE, Wren C, Scambler PJ, Burn J, Goodship J. 1994. Minimum prevalence of chromosome 22q11 deletions. Am J Hum Genet 55:A109.
3. Yankowitz J, Fulton A, Williamson R, Grant SS, Budelier WT. 1998. Prospective evaluation of prenatal maternal serum screening for trisomy 18. Am J Obstet Gynecol 178:446-450.